Enhanced Capital
Enhanced Capital, established in 1999, is a New York-based investment firm managing over $400 million. It specializes in providing flexible equity and debt financing to small and mid-sized businesses, promoting their growth and expansion. The firm's investment approach is practical and tailored, aiming to maximize the growth potential of companies poised for rapid growth. Enhanced Capital also invests in renewable energy, historic real estate rehabilitation, and affordable housing projects, often leveraging federal and state incentive programs.
Past deals in Medical Devices
SciAps
Debt Financing in 2013
SciAps, Inc. is a manufacturer of portable analytical instruments headquartered in Woburn, Massachusetts, with a facility in Laramie, Wyoming. Founded in 2012, the company specializes in developing field-hardened devices for the analysis of compounds, minerals, and elements. Its product lineup includes ReporteR, a Raman spectrometer for in-field applications; ObserveR, a handheld stand-off Raman system for detecting explosives and toxic substances; and PharmaID, a portable pharmaceutical identification tool. Additionally, SciAps offers Bench Top Spectrometers for analyzing various materials and provides reconditioned units of its Raman analyzers. The company serves diverse sectors, including food safety, pharmaceuticals, academic research, and law enforcement, through a network of salespeople and distributors. It also offers rental options for its equipment, emphasizing its commitment to providing accessible analytical solutions for various industries.
NovaTract Surgical
Series A in 2012
NovaTract Surgical, Inc. is a medical device company dedicated to enhancing minimally invasive surgical practices. Founded in 2010 and based in Madison, Connecticut, the company specializes in developing innovative solutions such as the NovaGrasp, a single-use laparoscopic grasper for tissue and organ retraction, and the NovaTract, a dynamic retractor designed for various surgical fields including colorectal, urologic, gynecologic, and robotic-assisted procedures. NovaTract Surgical aims to address the needs of the rapidly evolving fields of single-incision laparoscopic surgery and natural orifice transluminal endoscopic surgery, providing healthcare institutions with advanced tools to improve surgical outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.